Copyright
©The Author(s) 2004.
World J Gastroenterol. Apr 1, 2004; 10(7): 972-976
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Published online Apr 1, 2004. doi: 10.3748/wjg.v10.i7.972
Table 1 Sequential changes and comparisons of serum ferritin levels (μg/L) at different time points during lamivudine treatment between patients negative and positive for HBV DNA at end of treatment
Group | Baseline | Months after treatment | ||
3 | 6 | 12 | ||
HBV DNA ( - ) group (n = 19) | 231.20 ± 182.50 | 130.51 ± 110.21 | 96.25 ± 68.03 | 110.78 ± 83.37 |
HBV DNA ( + ) group (n = 19) | 187.42 ± 103.60 | 182.44 ± 107.15 | 154.92 ± 66.62 | 141.28 ± 86.48 |
P values | 0.371 | 0.150 | 0.013 | 0.283 |
- Citation: Liu ZW, Han QY, Zhang N, Kang W. Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B. World J Gastroenterol 2004; 10(7): 972-976
- URL: https://www.wjgnet.com/1007-9327/full/v10/i7/972.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i7.972